GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Intech Biopharm 6461.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

26.15

-2.06%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 107.5m

FY2016FY2025

Net income

−TWD 389.0m

FY2016FY2025

Free cash flow

−TWD 425.1m

FY2016FY2025

Shareholders' equity

TWD 1.10bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 107.5mTWD 39.8mTWD 25.8mTWD 23.6mTWD 38.9mTWD 21.1mTWD 16.7mTWD 17.2mTWD 16.6mTWD 11.7m
Research and developmentTWD 189.9mTWD 143.1mTWD 104.5mTWD 118.7mTWD 126.6mTWD 62.3mTWD 94.9mTWD 78.9mTWD 106.4mTWD 65.6m
Operating income−TWD 352.6m−TWD 339.8m−TWD 308.8m−TWD 306.8m−TWD 283.1m−TWD 234.3m−TWD 299.7m−TWD 231.0m−TWD 246.7m−TWD 132.1m
Net income−TWD 389.0m−TWD 368.2m−TWD 338.0m−TWD 327.9m−TWD 301.8m−TWD 250.4m−TWD 311.4m−TWD 222.1m−TWD 239.3m−TWD 125.5m
Diluted earnings per share-2.86-2.70-2.63-2.80-2.60-2.49-2.29-1.63-1.76-1.81

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.35bnTWD 2.40bnTWD 2.71bnTWD 2.55bnTWD 2.60bnTWD 2.62bnTWD 2.61bnTWD 2.51bnTWD 2.24bnTWD 2.10bn
Cash and short-term investments——TWD 598.1mTWD 374.9mTWD 335.5mTWD 304.7m———TWD 229.1m
Total liabilitiesTWD 1.25bnTWD 1.58bnTWD 1.54bnTWD 1.52bnTWD 1.26bnTWD 1.29bnTWD 1.04bnTWD 1.02bnTWD 887.5mTWD 507.3m
DebtTWD 994.9mTWD 1.19bnTWD 1.44bnTWD 1.41bnTWD 1.15bnTWD 1.18bnTWD 829.6mTWD 772.5mTWD 708.9mTWD 486.0m
Shareholders' equityTWD 1.10bnTWD 814.3mTWD 1.17bnTWD 1.03bnTWD 1.34bnTWD 1.33bnTWD 1.57bnTWD 1.49bnTWD 1.36bnTWD 1.59bn
Shares outstanding136m136m128m117m116m101m136m136m136m69m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 361.1m−TWD 269.2m−TWD 204.1m−TWD 190.4m−TWD 200.6m−TWD 167.4m−TWD 189.1m−TWD 232.4m−TWD 145.3m−TWD 165.2m
Capital spending−TWD 64.0m−TWD 43.6m−TWD 30.2m−TWD 11.0m−TWD 21.3m−TWD 48.2m−TWD 51.3m−TWD 204.0m−TWD 258.3m−TWD 317.6m
Free cash flow−TWD 425.1m−TWD 312.8m−TWD 234.3m−TWD 201.4m−TWD 221.9m−TWD 215.5m−TWD 240.4m−TWD 436.4m−TWD 403.6m−TWD 482.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 18.8mTWD 17.6mTWD 4.8mTWD 7.3mTWD 87.8mTWD 7.7mTWD 11.2mTWD 8.7m
Operating income−TWD 97.4m−TWD 104.3m−TWD 117.4m−TWD 137.0m−TWD 18.2m−TWD 80.0m−TWD 97.3m−TWD 88.7m
Net income−TWD 102.7m−TWD 111.9m−TWD 123.4m−TWD 144.1m−TWD 33.2m−TWD 88.4m−TWD 104.7m−TWD 96.0m
Diluted earnings per share-0.75-0.82-0.91-1.06-0.24-0.65-0.77-0.70
Cash from operations−TWD 85.0m−TWD 84.0m−TWD 64.0m−TWD 123.0m−TWD 75.0m−TWD 98.0m−TWD 64.0m−TWD 87.0m
Capital spending−TWD 14.0m−TWD 9.0m−TWD 9.0m−TWD 13.0m−TWD 14.0m−TWD 25.0m−TWD 3.0m−TWD 2.0m
Free cash flow−TWD 99.0m−TWD 93.0m−TWD 73.0m−TWD 136.0m−TWD 89.0m−TWD 123.0m−TWD 67.0m−TWD 89.0m
Total assetsTWD 2.30bnTWD 2.33bnTWD 2.35bnTWD 2.50bnTWD 2.73bnTWD 2.37bnTWD 2.40bnTWD 2.47bn
DebtTWD 1.15bnTWD 912.5mTWD 994.9mTWD 1.08bnTWD 1.14bnTWD 1.19bnTWD 1.19bnTWD 1.19bn
Shareholders' equityTWD 894.4mTWD 991.6mTWD 1.10bnTWD 988.0mTWD 1.13bnTWD 728.1mTWD 814.3mTWD 908.8m

Financial ratios

Data as of 21 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-324.3%-839.8%-1177.7%-1289.1%-725.5%-1106.6%
Net margin-361.8%-925.6%-1307.6%-1386.5%-775.7%-1186.3%
Return on equity-35.3%-45.2%-28.9%-31.8%-22.6%-18.8%
Return on assets-16.5%-15.4%-12.5%-12.9%-11.6%-9.6%
Free cash flow yield—-6.1%-5.0%-5.7%-5.7%-4.4%
Revenue growth170.3%53.9%9.3%-39.2%84.3%26.5%
Earnings growth5.7%8.9%3.1%8.7%20.5%-19.6%
Current ratio1.66x1.06x1.22x1.28x1.41x2.65x
Debt to equity0.90x1.46x1.23x1.37x0.86x0.89x
Equity ratio46.8%34.0%43.1%40.5%51.4%50.7%
Interest coverage-10.40x-9.78x-9.06x-13.23x-14.44x-13.89x
R&D as a share of sales176.6%359.6%404.2%501.9%325.5%295.3%
Buybacks as a share of market value—-6.1%-9.7%-0.6%-15.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue65.7%38.5%27.1%
Operating income4.8%8.5%11.3%
Net income5.9%9.2%12.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-470.1%-664.6%-710.8%-868.5%
Net margin-514.1%-723.1%-769.2%-909.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.1-15.8-18.4-18.7-12.1-13.0-12.6-18.0-37.1-29.8
Price to sales36.5146.1240.0259.194.2154.7235.2232.3—321.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.